May 4, 2021 For many scientists working in academia, the idea of switching careers to industry can be intimidating. But many scientists are making the move and are finding corporate work to be just as rewarding. One of them is Anuraag Sarangi of medical communications firm Precisionscientia.
After receiving a PhD in neuroscience from Vanderbilt University School of Medicine in 2009, Anuraag Sarangi s career path led him from basic research to the biopharma business, where he now works in medical communications.
During graduate school, Sarangi was focused on neuro-oncology research on novel molecular mechanisms regulating the growth of gliomas, which make up about 80% of all malignant brain tumors. The results of his research were published in
Share this article
Share this article
NEW YORK, April 14, 2021 /PRNewswire/ PRECISIONvalue, a Precision Value & Health team, today announced the further strategic expansion of its Access Experience Team (AET), a specialized group of former access decision markers, with the addition of Christy Banach. Christy s deep oncology practice background bolsters Precison s ability to futher drive strategic and implementation support related to real-time experiences being managed at the point of patient care within oncology practices.
To address the dynamic market access landscape, Precision has assembled the AET, an industry-leading group of 25+ former market access decision makers. As day-to-day leaders in access decision-making roles, AET members have an intimate understanding of the evolving drug marketplace and strong ties to their current industry. From this nuanced understanding of how market access stakeholders measure value and the supporting evidence, the AET works across Precis